Reglagene was one of 10 companies selected out of more than 300 applicants to pitch leaders from across Johnson & Johnson Innovation during the 2019 J.P. Morgan Healthcare Conference. JPM Week occurs annually in January and is the largest gathering of the pharma, biotech, and investor sectors. Johnson & Johnson Innovation launched the Quick Pitch to unearth the unseen and brightest innovations in healthcare. During the event on January 9, 2019, Reglagene made a tightly woven and compelling presentation that also served as the basis for conversations with prospective investors and pharmaceutical partners throughout the week. After the presentation, Johnson & Johnson awarded Reglagene a trophy for its participation. Reglagene’s CSO Laurence Hurley and CEO Richard Austin proudly pose with the prize.
Reglagene Selected to Participate in Johnson & Johnson Innovation Quick Pitch
Updated: Feb 27